Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

BioLabs (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today provided an ...

A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that combines four protein biomarkers can detect early-stage pancreatic cancer ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

ctDNA MRD monitoring may augment scans and tumor markers, enabling earlier detection of gastroesophageal cancer recurrence, especially hard-to-image peritoneal relapse.

Many people know that finding cancer early, before it spreads, may help increase the chances of treating and surviving cancer ...

If conducted every year or every other year, the multi-cancer early detection blood test could help more people survive cancer, researchers reported Thursday in BMJ Open. Adobe stock/HealthDay May 9 ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with ...

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...

A self-propelled nanoparticle engineered through computer simulation could bring laboratory-grade cancer detection to ...